Showing results (531-540 of 2,811) with videos related to
Sort By:
Pageof 282
Expert Opinion on Drug Safety|March 26, 2019
Safety and immunogenicity of pneumococcal conjugate vaccines in preterm infantsCarolina López-Sanguos, Irene Rivero Calle, Carmen Rodriguez Tenreiro, et al.Expert Opinion on Drug Safety|March 28, 2019
Safety and tolerability of available urate-lowering drugs: a critical reviewLarysa Strilchuk, Federica Fogacci, Arrigo Fg CiceroExpert Opinion on Drug Safety|November 16, 2018
The safety of dinutuximab for the treatment of pediatric patients with high-risk neuroblastomaKatie L Greenwood, Jennifer H FosterExpert Opinion on Drug Safety|April 8, 2017
Cardiovascular safety of liraglutide for the treatment of type 2 diabetesR A Chudleigh, Steve BainExpert Opinion on Drug Safety|October 13, 2016
Safety assessment of combination therapies in the treatment of obesity: focus on naltrexone/bupropion extended release and phentermine-topiramate extended releaseBruno Halpern, Marcio C ManciniExpert Opinion on Drug Safety|May 14, 2014
The problem of osteoporosis in epileptic patients taking antiepileptic drugsBarbara Miziak, Barbara Błaszczyk, Magdalena Chrościńska-Krawczyk, et al.Expert Opinion on Drug Safety|October 25, 2019
The safety and effectiveness of vonoprazan-based Helicobacter pylori eradication therapy; a prospective post-marketing surveillanceKiyoshi Ashida, Youichirou Honda, Katsuyuki Sanada, et al.Expert Opinion on Drug Safety|April 9, 2020
Safety of EGFR-TKIs for EGFR mutation-positive non-small cell lung cancerJia-Ying Zhou, Si-Yang Liu, Yi-Long WuExpert Opinion on Drug Safety|August 19, 2016
Efficacy and safety of infliximab in psoriatic patients over the age of 65Andrea Chiricozzi, Athanasios Pavlidis, Annunziata Dattola, et al.Expert Opinion on Drug Safety|May 26, 2015
Low-dose SoluMatrix diclofenac : a review of safety across two Phase III studies in patients with acute and osteoarthritis painAllan Gibofsky, Roy Altman, Stephen Daniels, et al.Pageof 282